{
    "2020-04-09": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pfizer's Braftovi Combo Gets FDA Nod for Colorectal Cancer",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Braftovi",
                        "FDA Nod",
                        "Colorectal Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Morgan Stanley Downgrades Lilly On Valuation, Says Growth, Pipeline Potential Balanced By Stock Premium",
                "features": {
                    "keywords": [
                        "Morgan Stanley",
                        "Downgrades",
                        "Lilly",
                        "Valuation",
                        "Growth",
                        "Pipeline Potential",
                        "Stock Premium"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: A10 Networks, Chemed, Core-Mark, Eli Lilly and Masimo",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "A10 Networks",
                        "Chemed",
                        "Core-Mark",
                        "Eli Lilly",
                        "Masimo"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse sectors"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "5 Stocks With Recent Price Strength Amid Coronavirus Logjam",
                "features": {
                    "keywords": [
                        "Price Strength",
                        "Coronavirus Logjam"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}